Pharmafile Logo
Pharmafocus logo
Advanced Search

Sanofi-Aventis

Showing 15 posts of 87 posts found.

Genzyme

Genzyme courting ‘white knight’ bid from Takeda

November 18, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, Takeda, pharma mergers

Genzyme is in talks with Takeda to secure a ‘white knight’ bid that would prevent Sanofi-Aventis from taking over the …

News

Genzyme again snubs suitor Sanofi

November 10, 2010
Research and Development, Sales and Marketing Campath, Chris Viehbacher, Genzyme, Henri Termeer, Orphan Drugs, Plavix, Sanofi, Sanofi-Aventis, manufacturing compliance

Genzyme has once again snubbed Sanofi-Aventis as the French pharma firm continues its pursuit of the beleaguered biotech company. Henri …

News

Rep’s shotgun request misfires

October 28, 2010
Sales and Marketing ABPI Code of Practice, PMCPCA, Sanofi-Aventis

Sanofi-Aventis has been found in breach of the ABPI Code over the conduct of one of its representatives in relation …

News

Sanofi moves teriflunomide into phase III MS trials

October 26, 2010
Research and Development MS, Sanofi, Sanofi-Aventis, TERACLES, multiple sclerosis, relapsing multiple sclerosis, teriflunomide

Sanofi-Aventis is to begin the first phase III study of an oral drug as an add-on to standard therapy in …

News

Staff blockade Sanofi-Aventis facility in France

October 21, 2010
Manufacturing and Production France, Sanofi, Sanofi-Aventis, job cuts, manufacturing and production

Workers at a Sanofi-Aventis manufacturing facility in Romainville, France, sealed off the gates of the plant to protest plans to …

News

Sanofi signs translational research deal with Harvard

October 18, 2010
Research and Development Harvard, Sanofi-Aventis, academia, translational

Sanofi-Aventis is to collaborate on translational biomedical research with Harvard University in therapy areas such as cancer, diabetes and inflammation. …

News

Sanofi slashes US workforce

October 11, 2010
Sales and Marketing Sanofi-Aventis, job cuts

Sanofi-Aventis is to cut a quarter of its workforce in the US – making 1,700 people redundant – as it …

News

Sanofi makes hostile offer for Genzyme

October 4, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis

Sanofi-Aventis’ courtship dance around Genzyme has turned more aggressive with an offer – made over the heads of Genzyme’s board …

News

Sanofi signs $2.2bn CRO deal

October 1, 2010
Research and Development CRO, Covance, Sanofi-Aventis

Sanofi-Aventis has signed a major deal to contract out a wide range of drug development and laboratory services as part …

News

Lixisenatide shaping up to rival Victoza

September 22, 2010
Research and Development Lixisenatide, Sanofi-Aventis, diabetes

Data for Sanofi-Aventis’ injectable lixisenatide suggests it could rival Novo Nordisk’s drug Victoza.Lixisenatide is a once-daily GLP-1 receptor agonist, and …

News
Multaq tablets

Sanofi’s Multaq in pole position for AF market

September 6, 2010
Sales and Marketing Multaq, Sanofi-Aventis, atrial fibrilation

New European Society of Cardiology guidelines on treating atrial fibrillation (AF) include a recommendation for Sanofi-Aventis’ Multaq. The endorsement is …

News

Genzyme available for ‘fair value’, says Termeer

September 2, 2010
Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis

Genzyme’s chief executive Henri Termeer has said his company could be for sale to Sanofi-Aventis if it offers a ‘fair …

News

Sanofi’s $18.5bn bid for Genzyme rejected

August 31, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis

Sanofi-Aventis has gone public with its $18.5 billion offer for Genzyme after the US biotech’s board unanimously rejected the bid …

News
Multaq

Multaq given limited approval from NICE

August 25, 2010
Medical Communications, Sales and Marketing Multaq, NICE, Sanofi-Aventis, atrial, dronedarone

NICE has given a restricted approval to Sanofi-Aventis’s Multaq as a second line treatment for atrial fibrillation patients. The guidance …

News

Sanofi signs personalised medicine alliance

August 11, 2010
Research and Development Sanofi-Aventis, Scripps Genomic Medicine, genomics

Sanofi-Aventis has signed a personalised medicine research alliance with US not-for-profit company Scripps Genomic Medicine. The company is part of …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026